Predictors of vascular remodelling in hypertensive subjects with well-controlled blood pressure levels

Journal of Human Hypertension

Volumn 29, Issue 9, 2015, Pages 561-565

  Puato, M ^a   Rattazzi, M ^a,b   Zanon, M ^a   Benetti, E ^a   Faggin, E ^a   Palatini, P ^a   Pauletto, P ^a,b  

^a UNIVERSITY OF PADOVA   (Italy)

^b OSPEDALE CA FONCELLO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OSTEOPROTEGERIN; TRIACYLGLYCEROL; ANTIHYPERTENSIVE AGENT; AUTACOID; BIOLOGICAL MARKER; TNFRSF11B PROTEIN, HUMAN;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; BLOOD PRESSURE REGULATION; BODY MASS; BRACHIAL ARTERY; CARDIOMETABOLIC RISK; CARDIOVASCULAR RISK; CAROTID ARTERY; CLINICAL ARTICLE; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; HUMAN; HYPERTENSION; MALE; PROSPECTIVE STUDY; BLOOD; BLOOD PRESSURE; CASE CONTROL STUDY; COMMON CAROTID ARTERY; DRUG EFFECTS; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PREDICTIVE VALUE; TREATMENT OUTCOME; VASCULAR REMODELING; VASODILATATION;

ADULT; ANTIHYPERTENSIVE AGENTS; BIOMARKERS; BLOOD PRESSURE; BRACHIAL ARTERY; C-REACTIVE PROTEIN; CAROTID ARTERY, COMMON; CAROTID INTIMA-MEDIA THICKNESS; CASE-CONTROL STUDIES; CHOLESTEROL, LDL; FEMALE; HUMANS; HYPERTENSION; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; OSTEOPROTEGERIN; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; TREATMENT OUTCOME; VASCULAR REMODELING; VASODILATION;

EID: 84939256337     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2014.121     Document Type: Article

References (29)

1. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson Jr SK. Carotidartery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 1999; 340(1): 14-22.
2. Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Common carotid intimamedia thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation 1997; 96(5): 1432-1437.
3. Bots ML, Evans GW, Riley WA, Grobbee DE. Carotid intima-media thickness measurements in intervention studies: design options, progression rates, and sample size considerations: a point of view. Stroke 2003; 34(12): 2985-2994.
4. Pauletto P, Palatini P, Da Ros S, Pagliara V, Santipolo N, Baccillieri S et al. Factors underlying the increase in carotid intima-media thickness in borderline hypertensives. Arterioscler Thromb Vasc Biol 1999; 19(5): 1231-1237.
5. Lemne C, Jogestrand T, de Faire U. Carotid intima-media thickness and plaque in borderline hypertension. Stroke 1995; 26(1): 34-39.
6. Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Desvarieux M et al. Mannheim intima-media thickness consensus. Cerebrovasc Dis 2004; 18(4): 346-349.
7. Deanfield J, Donald A, Ferri C, Giannattasio C, Halcox J, Halligan S et al. Endothelial function and dysfunction. Part I: Methodological issues for assessment in the different vascular beds: a statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension. J Hypertens 2005; 23 (1): 7-17.
8. Yeboah J, Folsom AR, Burke GL, Johnson C, Polak JF, Post W et al. Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: the multi-ethnic study of atherosclerosis. Circulation 2009; 120(6): 502-509.
9. Taddei S, Virdis A, Ghiadoni L, Sudano I, Salvetti A. Effects of antihypertensive drugs on endothelial dysfunction: clinical implications. Drugs 2002; 62(2): 265-284.
10. Ghiadoni L, Faita F, Salvetti M, Cordiano C, Biggi A, Puato M et al. Assessment of flow-mediated dilation reproducibility: a nationwide multicenter study. J Hypertens 2012; 30(7): 1399-1405.
11. Ghiadoni L, Magagna A, Versari D, Kardasz I, Huang Y, Taddei S et al. Different effect of antihypertensive drugs on conduit artery endothelial function. Hypertension 2003; 41(6): 1281-1286.
12. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005; 352(16): 1685-1695.
13. Kiechl S, Werner P, Knoflach M, Furtner M, Willeit J, Schett G. The osteoprotegerin/ RANK/RANKL system: a bone key to vascular disease. Expert Rev Cardiovasc Ther 2006; 4(6): 801-811.
14. Fadini GP, Rattazzi M, Matsumoto T, Asahara T, Khosla S. Emerging role of circulating calcifying cells in the bone-vascular axis. Circulation 2012; 125(22): 2772-2781.
15. Puato M, Palatini P, Zanardo M, Dorigatti F, Tirrito C, Rattazzi M et al. Increase in carotid intima-media thickness in grade I hypertensive subjects: white-coat versus sustained hypertension. Hypertension 2008; 51(5): 1300-1305.
16. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G et al. 2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESHESC Task Force on the Management of Arterial Hypertension. J Hypertens 2007; 25 (9): 1751-1762.
17. Palatini P, Graniero GR, Mormino P, Nicolosi L, Mos L, Visentin P et al. Relation between physical training and ambulatory blood pressure in stage I hypertensive subjects. Results of the HARVEST Trial. Hypertension and Ambulatory Recording Venetia Study. Circulation 1994; 90(6): 2870-2876.
18. Benetos A, Laurent S, Hoeks AP, Boutouyrie PH, Safar ME. Arterial alterations with aging and high blood pressure. A noninvasive study of carotid and femoral arteries. Arterioscler Thromb 1993; 13(1): 90-97.
19. Spence JD, Hegele RA. Noninvasive phenotypes of atherosclerosis. Arterioscler Thromb Vasc Biol 2004; 24(11): e188 author reply e-9.
20. Mancini GB, Dahlof B, Diez J. Surrogate markers for cardiovascular disease: structural markers. Circulation 2004; 109(25 Suppl 1): IV22-IV30.
21. Den Ruijter HM, Peters SA, Anderson TJ, Britton AR, Dekker JM, Eijkemans MJ et al. Common carotid intima-media thickness measurements in cardiovascular risk prediction: a meta-analysis. JAMA 2012; 308(8): 796-803.
22. Versari D, Daghini E, Virdis A, Ghiadoni L, Taddei S. Endothelium-dependent contractions and endothelial dysfunction in human hypertension. Br J Pharmacol 2009; 157(4): 527-536.
23. Masoura C, Pitsavos C, Aznaouridis K, Skoumas I, Vlachopoulos C, Stefanadis C. Arterial endothelial function and wall thickness in familial hypercholesterolemia and familial combined hyperlipidemia and the effect of statins. A systematic review and meta-analysis. Atherosclerosis 2011; 214(1): 129-138.
24. Vik A, Mathiesen EB, Brox J, Wilsgaard T, Njolstad I, Jorgensen L et al. Relation between serum osteoprotegerin and carotid intima media thickness in a general population - the Tromso Study. J Thromb Haemost 2010; 8(10): 2133-2139.
25. Chowienczyk PJ, Watts GF, Cockcroft JR, Ritter JM. Impaired endotheliumdependent vasodilation of forearm resistance vessels in hypercholesterolaemia. Lancet 1992; 340(8833): 1430-1432.
26. Griffiths CE, Iaccarino L, Naldi L, Olivieri I, Pipitone N, Salvarani C et al. Psoriasis and psoriatic arthritis: immunological aspects and therapeutic guidelines. Clin Exp Rheumatol 2006; 24(1 Suppl 40): S72-S78.
27. Zannettino AC, Holding CA, Diamond P, Atkins GJ, Kostakis P, Farrugia A et al. Osteoprotegerin (OPG) is localized to the Weibel-Palade bodies of human vascular endothelial cells and is physically associated with von Willebrand factor. J Cell Physiol 2005; 204(2): 714-723.
28. Ovchinnikova O, Gylfe A, Bailey L, Nordstrom A, Rudling M, Jung C et al. Osteoprotegerin promotes fibrous cap formation in atherosclerotic lesions of ApoE-deficient mice-brief report. Arterioscler Thromb Vasc Biol 2009; 29(10): 1478-1480.
29. Puato M, Faggin E, Rattazzi M, Paterni M, Kozakova M, Palombo C et al. In vivo noninvasive identification of cell composition of intimal lesions: a combined approach with ultrasonography and immunocytochemistry. J Vasc Surg 2003; 38 (6): 1390-1395.